Sana Biotechnology, Inc. (SANA) Cash Flow Statement
Sana Biotechnology, Inc. (SANA) generated -$132.2M of operating cash flow over the twelve months to 2026-06-30, spent $2.8M on capital expenditure and had free cash flow of -$135.1M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SANASana Biotechnology, Inc.Follow SANA — free
—
Price chart with a free account
- Market cap
- 697.5M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.25 | -0.29 | -0.25 | -0.22 | -0.14 | -0.13 | |
| Capital expenditure | 0.03 | 0.02 | 0.02 | 0.03 | 0.00 | -0.00 | |
| Free cash flow | -0.28 | -0.31 | -0.27 | -0.26 | -0.14 | -0.14 | |
| Stock-based compensation | 0.02 | 0.04 | 0.04 | 0.04 | 0.03 | — |
USD billions · SEC XBRL
Sana Biotechnology, Inc. — questions
- What is Sana Biotechnology, Inc.'s operating cash flow?
- -$132.2M over the twelve months to 2026-06-30.
- How much does Sana Biotechnology, Inc. spend on capital expenditure?
- $2.8M over the twelve months to 2026-06-30.
- What is Sana Biotechnology, Inc.'s free cash flow?
- -$135.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Sana Biotechnology, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.